Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Explore the main factors that move a stock index, including macroeconomic data, earnings, and policy changes that influence index levels.
21,956 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Two established players collide in a market shaped by AI data-center demand and inventory normalization. Microchip Te...
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
Two blue chips face opposite paths as rates stay high and consumer patterns shift. McDonald’s shows earnings growth w...
AI infrastructure is booming, but the real edge sits in data-center networking. This article explains the reason Aris...
Investors eyeing DEI in 2026 should study the Q1 results, leverage, and lease metrics that shape the office REIT's tr...
Payoneer’s quarterly results can illuminate how cross-border payments and freelance earnings ecosystems are evolving....
TSMC delivered a stronger-than-expected Q1 2026, lifting full-year targets as AI demand powers the cycle, fueling the...
President Trump arrives in Beijing for high-stakes talks with Xi Jinping, pressing to open up China for American inve...
This deep-dive breaks down senestech snes 2026 earnings for Q1, translating the numbers into practical signals for in...
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...